We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Check the tariff classification for peptide nisin standardised with sodium chloride
Guidance on the handling of slurry and manure to help reduce the spread of antibiotic resistant bacteria.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Find out about the long-term effects some people can have after having COVID-19.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Oct - 31 Dec 2023.
Guidance on sexual transmission of Zika virus and methods of prevention.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.